Anticoagulant Drugs, Diabetes Mellitus, Type 2
Conditions
Keywords
medicine reminder, diabetes mellitus, type 2, direct oral anticoagulants
Brief summary
In this study, the effect of an electronic device attached to a push through pill package and a smart phone application on chronic disease medication adherence is studied.
Detailed description
In this study study two different groups of medicine users are recruited. Both groups have 50 patients each. In the first study the participants are using oral medication for diabetes and in the second study the participants use new direct oral anticoagulants. Participants use medicine reminder system consisting of an electronic device and an smart phone application. In the beginning of the study the reminder system is collecting data on how the patients are taking their medication for the first two months. Smart phone application is not providing any reminders and participants can't access the app to see the details. After two months the application will be unlocked so that it starts reminding the users to take their medication at the right time. in this phase the patients can view their medication data from the application. The reminder phase of the study lasts for two months. After these two plus two months, the results are analyzed and published. The study continues after these four months for the next four months and after that, the long term results are analyzed.' The primary outcome is the possible change in the adherence between control and active period.
Interventions
DEVICEElectronic medicine reminder system
Electronic surveillance device is attached to the participants push through pill sheet and the smart phone application reminds the participants to take their medicine if they are about to take their daily dosage.
Sponsors
Helsinki University Central Hospital
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
Subjects are monitored first before the intervention and then during the intervention.
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* use of direct oral anticoagulants or oral diabetic drugs * age of 18 or more * subjects have been using a smart phone
Exclusion criteria
* patients who don't use their medication without help
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Adherence to the medication | 8 months | PDC - proportion of days covered |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Variation of daily pill taking times | 8 months | The mean difference from the mean pill taking time |
Countries
Finland
Outcome results
None listed